Safety of a novel VEGF-target antibody's ocular application
AIM:To verify the safety application of MIL60 in the treatment of corneal neovascularization both <i>in vivo</i> and <i>in vitro</i>. <p>METHODS: We observed the biological characteristics of human corneal epithelial cells. The cell proliferation was analyzed using CCK-...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Press of International Journal of Ophthalmology (IJO PRESS)
2017-11-01
|
Series: | Guoji Yanke Zazhi |
Subjects: | |
Online Access: | http://ies.ijo.cn/cn_publish/2017/11/201711007.pdf |